ArticleGastroenterology & hepatology2014
Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm.
Article in Gastroenterology & hepatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04720521 (Application of OpticalEnhancement Endoscopy（OE） in Diagnosis of Early Gastric Cancer), which is not on this map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Application of OpticalEnhancement Endoscopy（OE） in Diagnosis of Early Gastric Cancer: a Multicenter, Prospective, Randomized Controlled Study
Who cites it
16 citing papers in PubMed.
- Predictability of gastric intestinal metaplasia by patchy lavender color seen on linked color imaging endoscopy.Lasers in medical science · 2019Trial
- OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway.Molecular cancer · 2024Article
- Identifying the pre-malignant stomach: from guidelines to practice.Translational gastroenterology and hepatology · 2022Review
- International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021Article
- Application of linked color imaging in the diagnosis of early gastrointestinal neoplasms and precancerous lesions: a review.Therapeutic advances in gastroenterology · 2021Article
- Demographic Profile of Gastric Cancer in Afghanistan.Indian journal of surgical oncology · 2020Article
- The Small Bowel Cancer Incidence Enigma.Pathology oncology research : POR · 2020Review
- Ability of blue laser imaging with magnifying endoscopy for the diagnosis of gastric intestinal metaplasia.Lasers in medical science · 2018Article
- A Case-Control Study of the Association between Vitamin D Levels and Gastric Incomplete Intestinal Metaplasia.Nutrients · 2018Article
- The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review.Oncotarget · 2017Review
- Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases.Journal of cancer research and clinical oncology · 2017Article
- Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia.World journal of gastrointestinal endoscopy · 2017Article
- The use of optical imaging techniques in the gastrointestinal tract.Frontline gastroenterology · 2016Article
- The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes.Gastroenterology research and practice · 2015Article
- Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.PloS one · 2015Article
- Anatomical predilection of intestinal metaplasia based on 78,335 endoscopic cases.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer remains the fifth leading cancer diagnosis worldwide, and it is the third leading cause of cancer-related mortality. The incidence of gastric cancer within the United States, however, has remained substantially lower than elsewhere, which has led to a lack of screening and surveillance in clinical practice. Patients with known premalignant lesions, such as gastric intestinal metaplasia, which can increase the risk of gastric cancer by as much as 6-fold, might benefit from surveillance guidelines to detect gastric cancer at an earlier, potentially curative stage. Chro-moendoscopy with optical magnification, narrow-band imaging, and other image-enhanced endoscopic techniques are commercially available to assist in the diagnosis of premalignant gastric lesions and early gastric cancer. Furthermore, endoscopic mucosal resection and endoscopic submucosal dissection have become more widely available and offer potentially curative endoscopic resection for dysplastic lesions of the stomach and early gastric cancers, which is an alternative to traditional surgical resection.
Indexed as
Identifiers
25013389PMC4080873What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.